Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]
News [2595]
Articles [110]
Editorials [3]
Conferences [85]
elearning [27]
Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair
Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Comment on immunotherapy in lung cancer from the ECC 2013 Scientific Co-Chair ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
29 Sep 2013
Results for new antibody drug in non-small cell lung cancer
Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France
Results for new antibody drug in non-small cell lung cancer ( Prof Jean-Charles Soria - Institut Gustave Roussy, Villejuif, France )
29 Sep 2013
ecancerNews Highlights from August 2013
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancerNews Highlights from August 2013 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
8 Aug 2013
Government policy and engagement in cancer care
Dr Robert Thomas – Peter MacCallum Cancer Institute, Victoria, Australia
Government policy and engagement in cancer care ( Dr Robert Thomas – Peter MacCallum Cancer Institute, Victoria, Australia )
24 Jul 2013
Reducing lung cancer incidence and mortality worldwide
Prof David Zaridze – N.N. Blokhin Cancer Research Centre, Moscow, Russia
Reducing lung cancer incidence and mortality worldwide ( Prof David Zaridze – N.N. Blokhin Cancer Research Centre, Moscow, Russia )
24 Jul 2013
ECC 2013 Preview: Scientific programme highlights
Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013
Science behind phase I clinical trials: targeting tumour cell development...
Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
Science behind phase I clinical trials: targeting tumour cell development pathways ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013
ASCO 2013 highlights
Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
ASCO 2013 highlights ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013
Crizotinib superior to chemo for advanced ALK positive NSCLC
Dr Suresh S. Ramalingam - Emory University, Atlanta, USA
Crizotinib superior to chemo for advanced ALK positive NSCLC ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )
6 Jun 2013
Comment on progression free survival in lung cancer patients and the GALAXY-1...
Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA
Comment on progression free survival in lung cancer patients and the GALAXY-1 trial ( Dr Marjorie G. Zauderer - Memorial Sloan-Kettering Cancer Center, New York, USA )
3 Jun 2013
Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer
Dr Suresh S. Ramalingam - Emory University, Atlanta, USA
Ganetespib inhibits Hsp90 with docetaxel for advanced lung cancer ( Dr Suresh S. Ramalingam - Emory University, Atlanta, USA )
3 Jun 2013
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab
Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA
Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )
3 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation